These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18068664)

  • 1. The construction and in vitro testing of photo-activatable cancer targeting folated anti-CD3 conjugates.
    Thompson S; Dessi J; Self CH
    Biochem Biophys Res Commun; 2008 Feb; 366(2):526-31. PubMed ID: 18068664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics.
    Thompson S; Dessi J; Self CH
    MAbs; 2009; 1(4):348-56. PubMed ID: 20068406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of a novel fusion protein consisting of anti-CD3 antibody fused to recombinant interleukin-2.
    Lee KD; Chen HW; Chen CC; Shih YC; Liu HK; Cheng ML
    Oncol Rep; 2006 May; 15(5):1211-6. PubMed ID: 16596189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
    Henriksen G; Bruland OS; Larsen RH
    Anticancer Res; 2005; 25(1A):9-15. PubMed ID: 15816513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
    Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
    J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma.
    Turk MJ; Waters DJ; Low PS
    Cancer Lett; 2004 Sep; 213(2):165-72. PubMed ID: 15327831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion of chemotactic peptide to a single-chain bi-specific antibody (scBsAb) potentiates its cytotoxicity to target tumour cells.
    Song J; Wang X; Lei C; Piao J; Yin C; Zhang Z; Lin Q; Huang H
    Biotechnol Appl Biochem; 2006 Nov; 45(Pt 3):147-54. PubMed ID: 16836487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
    Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
    Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP
    ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
    Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
    J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light activation of anti-CD3 in vivo reduces the growth of an aggressive ovarian carcinoma.
    Thompson S; Stewart R; Smith JA; Self CH
    ChemMedChem; 2007 Nov; 2(11):1591-3. PubMed ID: 17979166
    [No Abstract]   [Full Text] [Related]  

  • 16. A new format of single chain tri-specific antibody with diminished molecular size efficiently induces ovarian tumor cell killing.
    Liu J; Zhao Q; Zhao B; Cheng J; Wang X; Song L; Zhong Z; Lin Q; Huang H
    Biotechnol Lett; 2005 Nov; 27(22):1821-7. PubMed ID: 16314977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cells.
    Bühler P; Molnar E; Dopfer EP; Wolf P; Gierschner D; Wetterauer U; Schamel WW; Elsässer-Beile U
    J Immunother; 2009; 32(6):565-73. PubMed ID: 19483653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.